Antidiabetic and vasoprotective activity of lithium: Role of glycogen synthase kinase-3

OBJECTIVES: Lithium is a drug of choice in maniac disorder. Lithium inhibits the glycogen synthase kinase-3 (GSK-3), an enzyme involved in the insulin signalling pathway. Elevated levels of GSK-3 were found in diabetic rats and humans. We aimed to determine the effect of lithium chloride in diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanzariya, Nilesh R., Patel, Rameshvar K., Patel, Natvar J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153708/
https://www.ncbi.nlm.nih.gov/pubmed/21845000
http://dx.doi.org/10.4103/0253-7613.83116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153708/
https://www.ncbi.nlm.nih.gov/pubmed/21845000
http://dx.doi.org/10.4103/0253-7613.83116

Ejemplares similares